Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation.

Martin Haas; Zdenka Leko-Mohr; Paul Roschger; Josef Kletzmayr; Christoph Schwarz; Christa Mitterbauer; Rudolf Steininger; Stefan Grampp; Klaus Klaushofer; Günter Delling

doi:10.1046/j.1523-1755.2003.00816.x

Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation.

Identifier:nobleid.org/w1/20260515/AFD36D0B

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AFD36D0B.svg?ark=w1%2F20260515%2FAFD36D0B)](https://nobleid.org/work/w1/20260515/AFD36D0B)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation.

Identifier:nobleid.org/w1/20260515/AFD36D0B

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AFD36D0B.svg?ark=w1%2F20260515%2FAFD36D0B)](https://nobleid.org/work/w1/20260515/AFD36D0B)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work